Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1α and glucose transporter 1 in non-small cell lung cancer

[1]  M. Okada,et al.  Difference in prognostic significance of maximum standardized uptake value on [18F]-fluoro-2-deoxyglucose positron emission tomography between adenocarcinoma and squamous cell carcinoma of the lung. , 2011, Japanese journal of clinical oncology.

[2]  K. Kinzler,et al.  Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells , 2009, Science.

[3]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[4]  M. Lerman,et al.  Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show? , 2009, Biochimica et biophysica acta.

[5]  R. Airley,et al.  Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies , 2008, Cancer Chemotherapy and Pharmacology.

[6]  S. Chellappan,et al.  Glut-1 antibodies induce growth arrest and apoptosis in human cancer cell lines. , 2007, Cancer letters.

[7]  Max Costa,et al.  Hypoxia-Inducible Factor-1 (HIF-1) , 2006, Molecular Pharmacology.

[8]  R. Cerfolio,et al.  The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. , 2005, The Journal of thoracic and cardiovascular surgery.

[9]  R. Airley,et al.  Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma? , 2003, British Journal of Cancer.

[10]  R. Airley,et al.  Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  H. Tonami,et al.  Correlation of Glut-1 glucose transporter expression with [18F]FDG uptake in non-small cell lung cancer , 2000, European Journal of Nuclear Medicine.

[12]  Y. Menda,et al.  A threshold method to improve standardized uptake value reproducibility , 2000, Nuclear medicine communications.

[13]  R. Coleman,et al.  The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma , 1998, Cancer.